NAMS

Q: What is the price of NewAmsterdam Pharma Company N.V. (NAMS) today?

The current price of NewAmsterdam Pharma Company N.V. (NAMS) is $ 32.11, representing a 71.8% gain over the past year. The stock began the year trading around $ 35.08 and is currently priced at $ 32.11. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does NewAmsterdam Pharma Company N.V. (NAMS) pay dividends?

NewAmsterdam Pharma Company N.V. (NAMS) did not pay dividends over the past year.

NewAmsterdam Pharma Company N.V.

Price

$ 32.11

return (12m)

71.80%

p/e

-19.32

p/bv

6.18

DIVIDEND YIELD

0.00%

NAMS price

NewAmsterdam Pharma Company N.V.

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NAMS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.54%

3 months

6.54%

1 year

71.80%

2 years

69.71%

5 years

230.69%

10 years

0.00%

Fundamentals NAMS

review the fundamentals of NewAmsterdam Pharma Company N.V. shares

P/E

-19.32

Sector: 7.47 Industry: 7.47

P/S (PSR)

182.13

Sector: 2.32 Industry: 2.32

P/BV

6.18

Sector: 2.26 Industry: 2.26

DIVIDEND YIELD (DY)

0.00%

Sector: 0.66% Industry: 0.66%

ROA

-29.03%

Sector: -0.36% Industry: -0.36%

ROE

-31.98%

Sector: 3.50% Industry: 3.50%

ROIC

-158.19%

Sector: -160.51% Industry: -160.51%

NET MARGIN

-100.00%

Sector: 2.97% Industry: 2.97%

GROSS MARGIN

100.00%

Sector: 32.00% Industry: 32.00%

OPERATING MARGIN

-100.00%

Sector: 4.81% Industry: 4.81%

EV/EBITDA

-19.12

Sector: 2.85 Industry: 2.85

EV/EBIT

-19.10

Sector: 1.19 Industry: 1.19

PRICE-TO-ASSETS

5.61

Sector: 1.07 Industry: 1.07

BVPS

5.45

Sector: 10.03 Industry: 10.03

EPS

-1.74

Sector: 0.70 Industry: 0.70

EQUITY-TO-ASSETS RATIO

0.91

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.09

Sector: 0.53 Industry: 0.53

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals NAMS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	22.71	6.58	28.97%	0.33%	$ 1.60 T	32.84%
INTR	292.53	37.99	12.99%	1.83%	$ 2.75 B	9.10%
PBR	5.99	1.42	23.78%	6.32%	$ 121.53 B	21.75%
VALE	24.33	1.85	7.59%	6.23%	$ 69.37 B	7.21%
PLTR	164.26	43.80	26.67%	0.00%	$ 374.76 B	43.67%
SHEL	12.57	1.35	10.74%	3.47%	$ 235.67 B	7.01%
BDORY	10.06	0.62	6.21%	2.79%	$ 23.52 B	8.65%
MAIN	10.93	1.51	13.78%	7.77%	$ 4.66 B	81.08%
NSRGY	11.15	6.29	56.41%	3.95%	$ 261.01 B	10.91%
ENB	23.46	2.39	10.18%	5.10%	$ 117.90 B	10.01%
PBR-A	5.35	1.27	23.78%	6.39%	$ 108.65 B	21.75%
ITUB	1,528.91	289.86	18.96%	1.98%	$ 87.36 B	12.16%
BBSEY	7.85	5.52	70.42%	11.67%	$ 13.35 B	100.00%
UNH	28.67	3.28	11.44%	2.32%	$ 345.32 B	2.68%
SAN	10.07	1.45	14.44%	1.62%	$ 189.11 B	27.40%
TTE	12.55	1.51	12.05%	6.43%	$ 189.31 B	8.20%
RACE	32.40	12.85	39.66%	1.25%	$ 60.22 B	22.18%
IONQ	78.54	5.15	6.56%	0.00%	$ 25.70 B	100.00%
TD	12.17	2.09	17.19%	2.71%	$ 190.81 B	34.54%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NAMS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V.

Average Investor10 user rating

4.0 (4 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

NewAmsterdam Pharma Company N.V. (United States) is listed on the Nasdaq and has a market capitalization of $4.11 Billions, with shareholders equity totaling $665.22 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, NewAmsterdam Pharma Company N.V. reported $22.56 Millions in revenue, generating net income of $-212.72 Millions.

Key financial metrics include a P/E ratio of -19.32, a price-to-book (P/B) ratio of 6.18, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NAMS.

Market cap

$ 4.11 Billions

Net worth

$ 665.22 Millions

$ 665,220,000.00

Assets

$ 732.64 Millions

$ 732,640,000.00

Total Shares Outstanding

122.00 Millions

122,000,000

Average Daily Trading Volume

$ 1.20 Million

$ 1,199,436.00

Sector

Others

Industry

Others

NAMS

NAMS revenue and profits

Financial Results NAMS

DRAG THE FRAME TO SEE MORE DATA

NAMS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

UNH - UnitedHealth Group Incorporated

$ 377.00 29,02% (12M)

P/E

28.67

2.32%

ROE

11.44%

P/BV

3.28

STLA - Stellantis NV

$ 7.35 --25,83% (12M)

P/E

-1.14

0.00%

ROE

-32.04%

P/BV

0.36

SSNLF - Samsung Electronics Co Ltd

$ - -0,00% (12M)

P/E

16.24

0.56%

ROE

17.46%

P/BV

2.84

CCOEY - Capcom Co Ltd ADR

$ 9.13 --37,84% (12M)

P/E

0.14

1.50%

ROE

20.55%

P/BV

0.03

COR - Cencora Inc.

$ 263.64 --8,09% (12M)

P/E

20.56

1.08%

ROE

71.09%

P/BV

14.62

SHEL - Shell PLC ADR

$ 86.77 35,39% (12M)

P/E

12.57

3.47%

ROE

10.74%

P/BV

1.35

NSRGY - Nestle SA ADR

$ 97.72 --4,18% (12M)

P/E

11.15

3.95%

ROE

56.41%

P/BV

6.29

META - Meta Platforms Inc.

$ 622.98 --9,09% (12M)

P/E

22.71

0.33%

ROE

28.97%

P/BV

6.58